Clinical Trials
Study Title:
An Open Label, Multicenter, Phase 1/2 Study of RP1 as a Single Agent and in Combination with PD1 Blockade in Patients with Solid Tumors
For more information about the trial above please contact the study team:
Medical University of South Carolina Principal Investigator, John Kaczmar, at kaczmar@musc.edu, or please call +1 843-792-6691. Study Coordinator, Madison Avinger, at avingerm@musc.edu.
Trial opened at the following institutions: Medical University of South Carolina |